SEI Investments
OLMA icon

SEI Investments’s Olema Pharmaceuticals OLMA Stock Holding History

SEI Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,259
Closed -$206K – 3300
2025
Q4 		$206K Buy
+8,259
New +$147K ﹤0.01% 2893
2024
Q1 		– Sell
-25,913
Closed -$364K – 2683
2023
Q4 		$364K Buy
+25,913
New +$348K ﹤0.01% 2240

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SEI Investments's OLMA Position: Q1 2026 in Review

SEI Investments sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 8,259 shares — an estimated $206K sold.

SEI Investments first reported a position in OLMA in Q4 2023 and held it in 2 quarters. The position peaked at $364K in Q4 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • SEI Investments reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SEI Investments sold 8,259 Olema Pharmaceuticals shares in Q1 2026, an estimated $206K.
  • SEI Investments first reported a position in Olema Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • SEI Investments's Olema Pharmaceuticals position peaked at $364K in Q4 2023.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.